Federal contract award
89243223FNE400097
PROGRAM INFORMATION COLLECTION SYSTEM AD SUPPORT SERVICES (PICSSS) - UNDER THIS TASK ORDER CONTRACT, THE CONTRACTOR WILL PROVIDE EXPERTISE AND SERVICES TO IMPLEMENT INDUSTRY STANDARD PROGRAM MANAGEMENT AND CONTROL PRINCIPLES TO INCLUDE PROJECT MANAG
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Energy |
| Office | IDAHO OPERATIONS OFFICE |
| NAICS | 541330 — Engineering Services |
| PSC | R425 — Engineering and Technical Services |
| Parent award / vehicle | GS10F053AA |
| Set-aside | WOMEN OWNED SMALL BUSINESS |
| Pricing type | TIME AND MATERIALS |
| Obligations | $42.6M |
| Current contract value | $98.0M |
| Potential contract value / ceiling | $98.0M |
| Start date | May 1, 2023 |
| Current end date | Apr 30, 2028 |
| Potential end date | Apr 30, 2028 |
| Latest award activity | Jul 17, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 42 of 42 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Sep 9, 2026 | P00041 | $3.4M | THE PURPOSE OF THIS MODIFICATION IS TO: 1. REALLOCATE $12,719,292.80 OF ESTIMATED COST CEILING FROM CLIN 0001 TO CLIN 0002 AS FOLLOWS: REDUCE THE CEILING ON CLIN 0001 BY ($12,719,292.80) FROM $97,953,140.00 TO $85,233,847.20. INCREASE THE CEILIN |
| Jul 17, 2026 | P00040 | $2.4M | THE PURPOSE OF THIS MODIFICATION IS TO: 1. ADD INCREMENTAL FUNDING OF $5,762,240.31 TO CLIN 00001, INCREASING THE TOTAL OBLIGATED AMOUNT FROM $41,427,048.24 TO $47,189,288.55. ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED. |
| Jul 13, 2026 | P00039 | $1.3M | THE PURPOSE OF THIS MODIFICATION IS TO: 1. ADD INCREMENTAL FUNDING OF $1,302,342.07 TO CLIN 00001, INCREASING THE TOTAL OBLIGATED AMOUNT FROM $40,124,706.17 TO $41,427,048.24. ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED. |
| Jun 5, 2026 | P00038 | $967.8K | THE PURPOSE OF THIS MODIFICATION IS TO: 1. ADD INCREMENTAL FUNDING OF $967,808.00 TO CLIN 00001, INCREASING THE TOTAL OBLIGATED AMOUNT FROM $39,156,898.17 TO $40,124,706.17. ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED. |
| Apr 22, 2026 | P00037 | $3.2M | THE PURPOSE OF THIS MODIFICATION IS TO: 1. ADD INCREMENTAL FUNDING OF $3,286,778.32 TO CLIN 00001, INCREASING THE TOTAL OBLIGATED AMOUNT FROM $35,870,119.85 TO $39,156,898.17. ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED. |
| Feb 24, 2026 | P00036 | $859.0K | THE PURPOSE OF THIS MODIFICATION IS TO: 1. ADD INCREMENTAL FUNDING OF $859,000.00 TO CLIN 00001, INCREASING THE TOTAL OBLIGATED AMOUNT FROM $35,011,119.85 TO $35,870,119.85. ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED. |
| Jan 16, 2026 | P00035 | $2.3M | THE PURPOSE OF THIS MODIFICATION IS TO: 1. ADD INCREMENTAL FUNDING OF $2,506,999.36 TO CLIN 00001, INCREASING THE TOTAL OBLIGATED AMOUNT FROM $32,504,120.49 TO $35,011,119.85. ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED. |
| Oct 29, 2025 | P00034 | $373.6K | THE PURPOSE OF THIS MODIFICATION IS TO: 1. ADD INCREMENTAL FUNDING OF $373,583.34 TO CLIN 00001, INCREASING THE TOTAL OBLIGATED AMOUNT FROM $32,130,537.15 TO $32,504,120.49. ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED. |
| Sep 26, 2025 | P00033 | $1.7M | THE PURPOSE OF THIS MODIFICATION IS TO: 1. REVISE THE LANGUAGE IN MOD P00032 FROM, DE-OBLIGATE INVOICE DISCOUNTS ON CLIN 00001 OF ($29,311.46), DECREASING THE OBLIGATED AMOUNT ON CLIN 00001 FROM $30,465,962.25 TO $30,436,650.79 TO DE-OBLIGATE INVOI |
| Sep 22, 2025 | P00032 | $-28.7K | THE PURPOSE OF THIS MODIFICATION IS TO: 1. DE-OBLIGATE INVOICE DISCOUNTS ON CLIN 00001 OF ($29,311.46), DECREASING THE OBLIGATED AMOUNT ON CLIN 00001 FROM $30,465,962.25 TO $30,436,650.79. ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED. |
| Sep 9, 2025 | P00031 | $1.7M | THE PURPOSE OF THIS MODIFICATION IS TO: 1. ADD INCREMENTAL FUNDING TO CLIN 00001 OF $1,843,844.80 INCREASING THE OBLIGATED AMOUNT FROM $28,622,117.45 TO $30,465,962.25. ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED. |
| Aug 14, 2025 | P00030 | $1.2M | THE PURPOSE OF THIS MODIFICATION IS TO: 1. ADD INCREMENTAL FUNDING TO CLIN 00001 OF $1,224,934.63 INCREASING THE OBLIGATED AMOUNT FROM $27,397,182.82 TO $28,622,117.45. ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED. |
| Jul 24, 2025 | P00029 | $1.5M | THE PURPOSE OF THIS MODIFICATION IS TO: 1. ADD INCREMENTAL FUNDING TO CLIN 00001 OF $1,501,979.00 INCREASING THE OBLIGATED AMOUNT FROM $25,895,203.82 TO $27,397,182.82. 2. DE-OBLIGATE FUNDS OF $169,175.05, SWAP, AND RE-OBLIGATE FUNDS OF $169,175.05 |
| Jun 17, 2025 | P00028 | $1.1M | THE PURPOSE OF THIS MODIFICATION IS TO: ADD INCREMENTAL FUNDING TO CLIN 00001 OF $1,293,189.78 INCREASING THE OBLIGATED AMOUNT FROM $24,602,014.04 TO $25,895,203.82. ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED. |
| Apr 28, 2025 | P00027 | $873.0K | THE PURPOSE OF THIS MODIFICATION IS TO: 1. ADD INCREMENTAL FUNDING TO CLIN 00001 OF $873,046.80 INCREASING THE OBLIGATED AMOUNT FROM $23,728,967.24 TO $24,602,014.04 ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED. |
| Feb 27, 2025 | P00026 | $2.4M | THE PURPOSE OF THIS MODIFICATION IS TO: 1. ADD INCREMENTAL FUNDING TO CLIN 00001 OF $2,438,029.60 INCREASING THE OBLIGATED AMOUNT FROM $21,290,937.64 TO $23,728,967.24. ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED. |
| Dec 18, 2024 | P00025 | $113.0K | THE PURPOSE OF THIS MODIFICATION IS TO: ADD INCREMENTAL FUNDING TO CLIN 00001 IN THE AMOUNT OF $222,360.00, INCREASING THE OBLIGATED AMOUNT FROM $21,068,577.64 TO $21,290,937.64. ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED. |
| Nov 8, 2024 | P00024 | $1.1M | THE PURPOSE OF THIS MODIFICATION IS TO: ADD INCREMENTAL FUNDING TO CLIN 00001 IN THE AMOUNT OF $1,054,371.00, INCREASING THE OBLIGATED AMOUNT FROM $20,014,206.64 TO $21,068,577.64. ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED. |
| Sep 30, 2024 | P00023 | $72.8K | THE PURPOSE OF THIS MODIFICATION IS TO: ADD INCREMENTAL FUNDING TO CLIN 00001 IN THE AMOUNT OF $72,815.53, INCREASING THE OBLIGATED AMOUNT FROM $19,941,391.11 TO $20,014,206.64. ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED. |
| Sep 27, 2024 | P00022 | $-39.4K | THE PURPOSE OF THIS MODIFICATION IS TO: 1. DE-OBLIGATE ($39,445.52) ON CLIN 00001 FOR INVOICE DISCOUNTS TAKEN, DECREASING THE OBLIGATED AMOUNT ON CLIN 00001 FROM $19,933,976.63 TO $19,894,531.11 AND THE TOTAL OBLIGATED AMOUNT FROM $19,980,836.63 TO |
| Sep 19, 2024 | P00021 | $740.0K | THE PURPOSE OF THIS MODIFICATION IS TO: ADD INCREMENTAL FUNDING TO CLIN 00001 IN THE AMOUNT OF $740,000.00, INCREASING THE TOTAL OBLIGATED AMOUNT FROM $19,240,836.63 TO $19,980,836.63. ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED.. |
| Sep 13, 2024 | P00020 | $2.2M | THE PURPOSE OF THIS MODIFICATION IS TO: ADD INCREMENTAL FUNDING TO CLIN 00001 IN THE AMOUNT OF $2,178,504.89, INCREASING THE TOTAL OBLIGATED AMOUNT FROM $17,062,331.74 TO $19,240,836.63. ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED. |
| Aug 16, 2024 | P00019 | $702.3K | THE PURPOSE OF THIS MODIFICATION IS TO: ADD INCREMENTAL FUNDING TO CLIN 00001 IN THE AMOUNT OF $956,432.87, INCREASING THE TOTAL OBLIGATED AMOUNT FROM $16,105,898.87 TO $17,062,331.74. ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED. |
| Aug 1, 2024 | P00018 | $1.5M | THE PURPOSE OF THIS MODIFICATION IS TO: 1. ADD INCREMENTAL FUNDING TO CLIN 00001 OF $1,462,619.03, INCREASING THE TOTAL OBLIGATED AMOUNT FROM $14,643,279.84 TO $16,105,898.87. 2. DE-OBLIGATE EXPIRING FY23 FUNDS OF $342,326.97. ALL OTHER TERMS AND |
| Jun 12, 2024 | P00017 | $336.0K | THE PURPOSE OF THIS MODIFICATION IS TO: 1. OBLIGATE $159.18 IN INVOICE CREDITS AND ADD INCREMENTAL FUNDING IN THE AMOUNT OF $335,799.97 TO CLIN 00001 INCREASING THE OBLIGATED AMOUNT ON CLIN 00001 BY $335,959.15 FROM $14,260,460.69 TO $14,596,419.84 |
| May 22, 2024 | P00016 | $-159 | THE PURPOSE OF THIS MODIFICATION IS TO: 1. DE-OBLIGATE $159.18 IN INVOICE CREDITS TAKEN, DECREASING THE TOTAL OBLIGATED AMOUNT FROM $14,307,479.87 TO $14,307,320.69. THIS DE-OBLIGATION OF FUNDS IS TO REALIGN THE DISCOUNTS RECEIVED ON INVOICES IN TH |
| May 21, 2024 | P00015 | $815.5K | THE PURPOSE OF THIS MODIFICATION IS TO: 1. ADD INCREMENTAL FUNDING IN THE AMOUNT OF $815,478.00 INCREASING THE TOTAL OBLIGATED AMOUNT FROM $13,492,001.87 TO $14,307,479.87. 2. ADD REVISED ATTACHMENT 2 - LABOR CATEGORY DESCRIPTIONS AND QUALIFICATION |
| Apr 9, 2024 | P00014 | $1.0M | THE PURPOSE OF THIS MODIFICATION IS TO: 1. ADD INCREMENTAL FUNDING IN THE AMOUNT OF $1,047,213.57 INCREASING THE TOTAL OBLIGATED AMOUNT FROM $12,444,788.30 TO $13,492,001.87. 2. ADD REVISED ATTACHMENT 1 - LABOR RATE TABLES AND ATTACHMENT 2 - LABOR |
| Mar 7, 2024 | P00013 | $1.8M | THE PURPOSE OF THIS MODIFICATION IS TO: 1. ADD INCREMENTAL FUNDING IN THE AMOUNT OF $1,786,115.00 INCREASING THE TOTAL OBLIGATED AMOUNT FROM $10,658,673.30 TO $12,444,788.30. ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED. |
| Feb 22, 2024 | P00012 | $1.0M | THE PURPOSE OF THIS MODIFICATION IS TO: 1. ADD INCREMENTAL FUNDING IN THE AMOUNT OF $1,002,122 INCREASING THE TOTAL OBLIGATED AMOUNT FROM $9,656,551,30 TO $10,658,673.30. ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED. |
| Jan 26, 2024 | P00011 | $0 | THE PURPOSE OF THIS MODIFICATION IS TO: 1. UPDATE B.3 CLIN 001 FROM FIRM FIXED PRICE TO TIME & MATERIALS. 2. UPDATE B.3 CLIN 002 FROM TIME & MATERIALS TO FIRM FIXED PRICE. 3. RECAST FUNDS FROM CLIN 00001 TO CLIN 00002 IN THE AMOUNT OF $23 |
| Jan 19, 2024 | P00010 | $716.0K | THE PURPOSE OF THIS MODIFICATION IS TO ADD INCREMENTAL FUNDING IN THE AMOUNT OF $716,020.77 AND INCREASE THE 5-YEAR TIME AND MATERIAL TASK ORDER CEILING CAP FROM $49M TO $98M. |
| Nov 21, 2023 | P00009 | $292.7K | THE PURPOSE OF THIS MODIFICATION IS TO: 1. ADD INCREMENTAL FUNDING IN THE AMOUNT OF $292,662.61 INCREASING THE TOTAL OBLIGATED AMOUNT FROM $8,647,867.92 TO $8,940,530.53. ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED. |
| Sep 28, 2023 | P00006 | $2.3M | THE PURPOSE OF THIS MODIFICATION IS TO: ADD INCREMENTAL FUNDS IN THE AMOUNT OF $2,310,925.63 INCREASING THE TOTAL OBLIGATED AMOUNT FROM $6,352,008.62 TO $8,662,934.25. ALL OTHER TERMS AND CONDITIONS REMAIN THE SAME. |
| Sep 28, 2023 | P00007 | $0 | THE PURPOSE OF THIS MODIFICATION IS TO: 1. ADD CLIN 00002-HONORARIUMS / STIPENDS - FIRM FIXED PRICE 2. DE-OBLIGATE $23,320.00 DECREASING THE OBLIGATED AMOUNT FROM $8,662,934.25 TO $8,639,614.25 THIS ACTION DECREASES THE CEILING FROM $49,000,000 TO |
| Sep 28, 2023 | P00008 | $-15.1K | THE PURPOSE OF THIS MODIFICATION IS TO: 1. DE-OBLIGATE $15,066.33 DECREASING THE OBLIGATED AMOUNT FROM $8,639,614.25 TO $8,624,547.92. THIS ACTION DECREASES THE TOTAL OBLIGATED AMOUNT FROM $8,662,934.25 TO $8,647,867.92. ALL OTHER TERMS AND |
| Sep 20, 2023 | P00005 | $0 | THE PURPOSE OF THIS MODIFICATION IS TO: 1.CORRECT AN INTERNAL ACCOUNTING ISSUE. TOTAL OBLIGATIONS REMAINED UNCHANGED AND NO OTHER CHANGES HAVE BEEN MADE. |
| Aug 30, 2023 | P00004 | $2.4M | THE PURPOSE OF THIS MODIFICATION IS TO: 1. ADD INCREMENTAL FUNDING IN THE AMOUNT OF $2,425,180.32 INCREASING THE TOTAL OBLIGATED AMOUNT FROM $3,926,828.30 TO $6,352,008.62. ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED. |
| Aug 14, 2023 | P00003 | $3.5M | THE PURPOSE OF THIS MODIFICATION IS TO, 1. ADD INCREMENTAL FUNDING IN THE AMOUNT OF $3,671,400.18 INCREASING THE TOTAL OBLIGATED AMOUNT FROM $255,428.12 TO $3,926,828.30. 2. UPDATE THE COR TO NATHAN MCBRIDE AND ALTERNATE COR TO JAMES JARDINE. AL |
| Jul 18, 2023 | P00002 | $0 | THE PURPOSE OF THIS MODIFICATION IS TO MAKE ADMINISTRATIVE UPDATES TO: 1. ADD FAR CLAUSE 52.204-27, PROHIBITION ON A BYTEDANCE COVERED APPLICATION PER INTERIM RULE AMENDING THE FEDERAL ACQUISITION REGULATION (FAR) TO IMPLEMENT A SECTION OF THE CONSO |
| May 24, 2023 | P00001 | $0 | THE PURPOSE OF THIS MODIFICATION IS TO MAKE ADMINISTRATIVE UPDATES TO: 1. SECTION C 2. SECTION E 3. SECTION F 4. SECTION G 5. SECTION H 6. SECTION I 7. SECTION J ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED. |
| Apr 26, 2023 | 0 | $255.4K | PROGRAM INFORMATION COLLECTION SYSTEM AD SUPPORT SERVICES (PICSSS) - UNDER THIS TASK ORDER CONTRACT, THE CONTRACTOR WILL PROVIDE EXPERTISE AND SERVICES TO IMPLEMENT INDUSTRY STANDARD PROGRAM MANAGEMENT AND CONTROL PRINCIPLES TO INCLUDE PROJECT MANAG |
Estimated positioning window
Apr 30, 2027 – Oct 30, 2027
Recompete signal: . Rule-based research score; positioning dates are estimates.
75/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 75/100. Available recorded signals: 70 points.
- Contract end 2028-04-30 (553 days from calculation)
- +25 points
- 26 historical awards in this buyer and category group
- +15 points
- 42 recorded award transactions
- +10 points
- Latest award action: 2026-07-17
- +5 points
- Parent award identifier recorded
- +5 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-10-25 10:18:04.631876+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Oct 25, 2026.
Buyer contacts from matching notices
Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| Thomas, Rachel R. | Contact | thomasrr@id.doe.gov 208-526-7283 | Source | Jan 18, 2023 |
| Thomas, Rachel R. | Contact | thomasrr@id.doe.gov 208-526-7283 | Source | Jan 4, 2023 |
| Thomas, Rachel R. | Contact | thomasrr@id.doe.gov 208-526-7283 | Source | Dec 13, 2022 |
| Thomas, Rachel R. | Contact | thomasrr@id.doe.gov 208-526-7283 | Source | Dec 10, 2022 |
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.